Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant α1β3γ2L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 95 (4) , 408-417
Abstract
Background: Propofol, etomidate, and barbiturate anesthetics are allosteric co-agonists at pentameric α1β3γ2 GABAA receptors, modulating channel activation via four biochemically established inter-subunit transmembrane pockets. Etomidate selectively occupies the two β+/α— pockets, the barbiturate photolabel R-mTFD-MPAB occupies homologous α+/β— and γ+/β— pockets, and propofol occupies all four. Functional studies of mutations at M2-15′ or M3-36′ loci abutting these pockets provide conflicting results regarding their relative contributions to propofol modulation. Methods: We electrophysiologically measured GABA-dependent channel activation in α1β3γ2L or receptors with single M2-15′ (α1S270I, β3N265M, γ2S280W) or M3-36′ (α1A291W, β3M286W, γ2S301W) mutations, in the absence and presence of equi-potent clinical range concentrations of etomidate, R-mTFD-MPAB, and propofol. Estimated open probabilities were calculated and analyzed using global two-state Monod-Wyman-Changeux models to derive log(d) parameters proportional to anesthetic-induced channel modulating energies. Results: All mutations reduced log(d)s for anesthetics occupying both abutting and non-abutting pockets. The Δlog(d)s [log(d, mut) – log(d, wt)] for M2-15′ mutations abutting an anesthetic’s biochemically established binding sites were consistently larger than Δlog(d)s for non-abutting mutations, although this was not true for M3-36′ mutant Δlog(d)s. The sums of anesthetic-associated Δlog(d)s for sets of M2-15′ or M3-36′ mutations were all much larger than wild-type log(d)s. Conclusions: Mutant Δlog(d)s qualitatively reflect anesthetic site occupancy patterns. However, the lack of Δlog(d) additivity undermines quantitative comparisons of distinct site contributions to anesthetic modulation, because the mutations impaired both abutting anesthetic binding effects and positive cooperativity between anesthetic binding sites.Keywords
This publication has 39 references indexed in Scilit:
- Monod–Wyman–Changeux allosteric mechanisms of action and the pharmacology of etomidateCurrent Opinion in Anaesthesiology, 2012
- Two Etomidate Sites in α1β2γ2 γ-Aminobutyric Acid Type A Receptors Contribute Equally and Noncooperatively to Modulation of Channel GatingAnesthesiology, 2012
- An Allosteric Coagonist Model for Propofol Effects on α1β2γ2L γ-Aminobutyric Acid Type A ReceptorsAnesthesiology, 2012
- Mutations in the GABAA Receptor that Mimic the Allosteric Ligand Etomidate2011
- γ-Amino Butyric Acid Type A Receptor Mutations at β2N265 Alter Etomidate Efficacy While Preserving Basal and Agonist-dependent ActivityAnesthesiology, 2009
- GABAA receptors: Subtypes provide diversity of function and pharmacologyNeuropharmacology, 2009
- Tryptophan Mutations at Azi-Etomidate Photo-Incorporation Sites on α1 or β2 Subunits Enhance GABAA Receptor Gating and Reduce Etomidate ModulationMolecular Pharmacology, 2008
- Identification of a GABAAReceptor Anesthetic Binding Site at Subunit Interfaces by Photolabeling with an Etomidate AnalogJournal of Neuroscience, 2006
- Gating Allosterism at a Single Class of Etomidate Sites on α1β2γ2L GABAA Receptors Accounts for Both Direct Activation and Agonist ModulationJournal of Biological Chemistry, 2004
- Tryptophan scanning mutagenesis in TM2 of the GABAA receptor α subunit: effects on channel gating and regulation by ethanolBritish Journal of Pharmacology, 2000